US Food and Drug Administration (USFDA) offers four Expedited Programs (EPs): Accelerated Approval (AA), Fast Track designation (FT), Breakthrough Therapy designation (BT) and Priority Review (PR). As Gadekar recently presented, understanding the frequency of EP assignment and application types is useful to inform regulatory strategies. This letter builds upon the previous analysis by examining the association between EPs and...

Ghost pipefishes (Solenostomidae) have been regarded as specialist crustacean feeders since the 1960s, an inference resting on two primary dietary accounts. We report the first documented evidence of piscivory in the family based on micro‐computed tomography (micro‐CT) examination of voucher specimens of Solenostomus snuffleupagus and S. cyanopterus . Two head‐first teleost prey, both identified as gobiids, were recovered from...

Purpose Approximately half of triple-negative breast cancer (TNBC) patients attain a complete response to neoadjuvant therapy (NAT). Thus, methods to predict and optimize NAT response are essential to improving patient outcomes. Methods Previously, mathematical models with a reaction term describing cell growth and death and a diffusion term describing cell invasion have accurately forecasted NAT response but have had limited...